William R. Lenderking

Biography

Dr. Lenderking is a licensed clinical psychologist in Massachusetts, and was most recently a Vice President, Science at Evidera, where he worked for 17 years. He has over 30 years’ experience in the field of outcomes research, starting with a position as a post-doc at Harvard School of Public Health with the AIDS Clinical Trials Group. He has held positions at Harvard Medical School, in independent psychology practice, and with several consulting companies including Phase V Technologies and Abt Associates. He was with Pfizer Inc. for 7 years as Director of Worldwide Outcomes Research. While there, he developed the daily version of the Quick Inventory of Depression Scale with Dr John Rush. At Evidera, he has completed studies in many areas including neuroscience, oncology, and rare disease. For example, he was the Project Director for the Cognition Initiative, a multi-sponsor consortium project with the Critical Path Institute to develop a new measure of the earliest symptoms of mild cognitive impairment. He has been developing questionnaires for over 30 years, and has over 70 peerreviewed articles, chapters, and published letters, in journals such as New England Journal of Medicine, Annals of Internal Medicine, Journal of General Internal Medicine, Public Health Reports, Journal of Trauma, Journal of Personality Assessment, Value in Health, Pharmacoeconomics, and Quality of Life Research. William published a book co-edited with Dennis Revicki, titled Advancing Health Outcomes Research Methods and Clinical Applications. He served as Associate Editor of Quality of Life Research (2000-2003), and was co-editor of Value in Health from 1999-2008, and recently was a guest editor for a special issue of Quality of Life Research devoted to clinical meaningfulness.